|
05 Jan 2011 |
Medicago announces Publication of its Phase I Study with its Pandemic H5N1 Influenza Virus-Like Particle (VLP) Vaccine Candidate
|
|
05 Jan 2011 |
Profectus BioSciences Announces Initiation of Clinical Trial of IL-12 Enhanced Therapeutic HIV DNA Vaccine Delivered Using Electroporation
|
|
05 Jan 2011 |
Opexa Completes Successful Meetings with FDA to Pursue Phase 3 Clinical Study for Tovaxin in Multiple Sclerosis
|
|
04 Jan 2011 |
ImmunoCellular Therapeutics Receives FDA Approval to Commence Phase II Trial of ICT-107
|
|
04 Jan 2011 |
NOVAVAX Launches Phase I Clinical Trial to Evaluate its Novel Vaccine Against Respiratory Syncytial Virus (RSV)
|
|
28 Dec 2010 |
Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
|
|
28 Dec 2010 |
Emergent BioSolutions Starts Phase I Clinical Trial for Third Generation Anthrax Vaccine
|
|
23 Dec 2010 |
Dynavax Reports Phase 1B Safety and Immunogenicity Results for Hepatitis B Therapy Candidate
|
|
23 Dec 2010 |
US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL
|
|
22 Dec 2010 |
Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13, in Adults 50 and Older
|
|
22 Dec 2010 |
NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate
|
|
22 Dec 2010 |
Medicago updates on progress with Phase II clinical testing of its avian influenza vaccine candidate
|
|
21 Dec 2010 |
The PATH Malaria Vaccine Initiative, Merck and NYU Langone Medical Center Collaborate to Research Potential Malaria Vaccine
|
|
21 Dec 2010 |
Joint Development of Therapeutic Cancer Vaccine WT4869
|
|
20 Dec 2010 |
Phylogica Signs Collaboration and Licensing Deal with Pfizer
|
|
16 Dec 2010 |
NOVAVAX Receives FDA Clearance to Launch Phase I RSV Vaccine Clinical Trial
|
|
14 Dec 2010 |
Profectus Biosciences’ GENEVAX IL-12 Adjuvant Significantly Improves pDNA Vaccine Performance in Phase I Human Trial
|
|
13 Dec 2010 |
Phase III Data Leads Intercell AG to Shelve Late-Stage Traveler’s Diarrhea Vaccine Patch
|
|
09 Dec 2010 |
Bavarian Nordic Receives Special Protocol Assessment Agreement from the FDA for Phase 3 Trial of PROSTVAC
|
|
09 Dec 2010 |
GeoVax Labs: Excellent Safety and Reproducible Immunogenocity Demonstrated in Early Results of Phase 2a Trial for HIV Preventative Vaccine
|
|
09 Dec 2010 |
Argos Therapeutics' Arcelis HIV Immunotherapy Shows Feasibility to Generate Fully Functional Dendritic Cells From Viremic Patients
|
|
08 Dec 2010 |
Preclinical Efficacy of Inovio Pharmaceuticals’ Smallpox DNA Vaccine Featured in The Journal of Infectious Diseases
|
|
08 Dec 2010 |
SEEK Announces Positive Phase I Data for Universal Flu Vaccine at World Influenza Congress
|
|
07 Dec 2010 |
Radient Pharmaceuticals Announces Formation of New Subsidiary NuVax Therapeutics Inc.
|
|
07 Dec 2010 |
Aduro BioTech’s Clinical Results from CRS-207 Phase 1 Trial Presented at AACR Special Conference
|
